Nabriva Therapeutics plc - Ordinary Shares (NBRV): Price and Financial Metrics
Nabriva Therapeutics plc - Ordinary Shares (NBRV)
Today's Latest Price: $2.84 USD
Updated Jan 27 8:33am
Add NBRV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBRV Stock Summary
- With a price/sales ratio of 153.38, Nabriva Therapeutics plc has a higher such ratio than 97.1% of stocks in our set.
- As for revenue growth, note that NBRV's revenue has grown -70.84% over the past 12 months; that beats the revenue growth of merely 2.43% of US companies in our set.
- The volatility of Nabriva Therapeutics plc's share price is greater than that of 97.99% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Nabriva Therapeutics plc are APDN, ICAD, AVGR, MBII, and HTGM.
- NBRV's SEC filings can be seen here. And to visit Nabriva Therapeutics plc's official web site, go to www.nabriva.com.
NBRV Stock Price Chart Interactive Chart >
NBRV Price/Volume Stats
| Current price | $2.84 | 52-week high | $16.50 |
| Prev. close | $2.95 | 52-week low | $2.31 |
| Day low | $2.84 | Volume | 16,974 |
| Day high | $2.84 | Avg. volume | 844,063 |
| 50-day MA | $3.25 | Dividend yield | N/A |
| 200-day MA | $5.66 | Market Cap | 428.24M |
Nabriva Therapeutics plc - Ordinary Shares (NBRV) Company Bio
Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company was founded in 2006 and is based in Wien, Austria.
Loading social stream, please wait...